1
Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic Pain
Condition(s):Neuropathic PainLast Updated:August 28, 2017Terminated
Loxapine as an Intervention: 35 Clinical Trials, Page 1 of 4
Hide Studies Not Open or Pending
2
A Study of Staccato Loxapine (ADASUVE®) for Inhalation
Condition(s):Psychomotor Agitation; Schizophrenia; Bipolar DisorderLast Updated:November 5, 2019Unknown status
3
Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder
Condition(s):Agitation,PsychomotorLast Updated:October 19, 2020Recruiting
4
Phase IV to Evaluate the Safety of Self-administered ADASUVE® in Agitated Patients Outside the Hospital Setting
Condition(s):AgitationLast Updated:November 4, 2020Completed
5
Staccato Loxapine in Agitated Patients With Schizophrenia
Condition(s):Patients With Schizophrenia and Acute AgitationLast Updated:July 26, 2017Completed
6
Staccato Loxapine Pulmonary Safety in Patients With Asthma
Condition(s):AsthmaLast Updated:March 15, 2017Completed
7
Staccato Loxapine PK in Smokers and Nonsmokers
Condition(s):Smoking, CigaretteLast Updated:March 15, 2017Completed
8
Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation
Condition(s):Agitation,Psychomotor; Haloperidol Causing Adverse Effects in Therapeutic Use; Lorazepam Causing Adverse Effects in Therapeutic Use; Loxapine Causing Adverse Effects in Therapeutic UseLast Updated:June 11, 2018Terminated
9
Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic Medication
Condition(s):BiPolarLast Updated:February 29, 2016Completed
10
Staccato Loxapine in Migraine (in Clinic)
Condition(s):MigraineLast Updated:July 6, 2017Completed